Directory
>
Chen Schor
Chen Schor
President and CEO | Karyopharm Therapeutics Inc.
Massachusetts, Boston, United States
Chen Schor
Summary
Chen Schor is a seasoned executive with extensive experience in the biotechnology sector, currently serving as the President and CEO of Adicet Bio, Inc. He has a proven track record of leading biotech companies through various stages of development, transforming them into publicly traded entities with significant partnerships with major pharmaceutical companies. Chen has successfully orchestrated strategic transactions exceeding $8 billion and raised over $300 million in funding. His leadership roles span various organizations, including Karyopharm Therapeutics and Teva Pharmaceuticals, where he has driven business development and pipeline management. With an educational background that includes an MBA and dual bachelor's degrees in Biology and Economics, Chen is also a Certified Public Accountant. His expertise lies in partnerships, management, and venture capital, making him a key player in the industry.
Chen Schor
Work Experience
Board Member at
Alliance for Cancer Gene Therapy
December 2021 - Present
Frequently Asked Questions about Chen Schor
What is Chen Schor email address?
Chen Schor's primary email address is ****@schornet.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Chen Schor work for?
Chen Schor is a President and CEO at Karyopharm Therapeutics Inc..
How can I directly contact Chen Schor?
To contact Chen Schor directly, you can use the email address ****@schornet.com. Complete contact information is available upon registration with Muraena.
Who is Chen Schor?
Chen Schor is a seasoned executive with extensive experience in the biotechnology sector, currently serving as the President and CEO of Adicet Bio, Inc. He has a proven track record of leading biotech companies through various stages of development, transforming them into publicly traded entities with significant partnerships with major pharmaceutical companies. Chen has successfully orchestrated strategic transactions exceeding $8 billion and raised over $300 million in funding. His leadership roles span various organizations, including Karyopharm Therapeutics and Teva Pharmaceuticals, where he has driven business development and pipeline management. With an educational background that includes an MBA and dual bachelor's degrees in Biology and Economics, Chen is also a Certified Public Accountant. His expertise lies in partnerships, management, and venture capital, making him a key player in the industry.
Chen`s contact details
****@schornet.com
******@acgtfoundation.org
******@adicetbio.com
Colleagues
Project Coordinator
Research Scientist
Business Developer
Sales Representative
Research Associate
Co-Op
Scientist
Quality Control Technician/Customer Service Manager
Senior Product Manager
Sr. Manager, Publications